105.45
+0.91%
Close of 9 Nov 2026, in CHF
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Straumann Holding
Its shares trade on SIX under the ticker STMN.SW. It has been listed since 1 June 1998. In the fiscal year to 31 December 2025, it reported revenue of CHF 2.60bn and net income of CHF 355.9m. At that date it held total assets of CHF 3.82bn and shareholders' equity of CHF 2.16bn.
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. The company is headquartered in Basel, Basel-Stadt. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 Jun 1998
- Employees
- 7,494
- Website
- straumann.com ↗
Leadership
Pay as last reported
- Ms. Petra RumpfNon-Executive Independent Chairman of the Board, since 2015CHF 764,000
- Mr. Guillaume DaniellotChief Executive Officer, Member of the Executive Management BoardCHF 4.7m
- Dr. H. C. StraumannNon-Executive Independent Vice Chairman of the Board, since 2022CHF 214,000
- Ms. Yang XuChief Financial Officer, Member of the Executive Management Board
- Mr. Sebastien RocheMember of the Executive Management Board, Chief Operations Officer
- Mr. Arnoud MiddelMember of the Executive Board, Chief People Officer
- Mr. Alexei CostaMember of the Executive Board Executive Vice President - Latin America and President Neodent
- Mr. Thomas FrieseMember of the Executive Board, Chief Technology and Information Officer
- Ms. Sara DalmassoMember of the Executive Board, Head of Straumann Group Enterprise Solutions
- Mr. Holger HadererMember of the Executive Management Board, Regional Head Europe, Middle East & Africa
- Mr. Florian KirschMember of the Executive Management Board, Head of Connected Customer Solutions and Orthodontics Business Unit
- Mr. Patrick LohMember of the Executive Management Board, Regional Head Asia Pacific
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 83
- Environment
- 84
- Social
- 99
- Governance
- 65
- Direct emissions (scope 1)
- 8,781 t
- Energy emissions (scope 2)
- 13,027 t
- Value chain emissions (scope 3)
- 298,182 t
- Women in the workforce
- 46%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Straumann Holding AG employs 7,494 full-time employees to support its global operations.
- The company is headquartered in Basel, Basel-Stadt, serving as the central hub for its business activities.
- Straumann collaborates with the International Team for Implantology (ITI) to provide training and education services to the dental profession worldwide.
Weaknesses
- The company's operations are concentrated in a single headquarters location in Basel, Basel-Stadt.
- Straumann Holding AG relies on a specific network of subsidiaries and technology partners rather than owning all distribution channels directly.
- The business model depends heavily on collaboration with external clinics, research institutes, and universities for its research and development efforts.
Opportunities
- The company can expand its reach through its existing network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region, and Latin America.
- Straumann can leverage its collaboration with research institutes and universities to further develop computer-aided design/manufacturing (CAD/CAM) prosthetics.
- The firm can grow its presence in the Asia/Pacific region and Latin America by utilizing its established network of technology partners.
Threats
- Competitors in the Health Care sector may develop superior implant, restorative, and regenerative dentistry solutions.
- Changes in the regulatory environment for dental professionals and laboratories could impact the demand for Straumann's products.
- Economic fluctuations in key markets such as Europe, North America, or Latin America could affect the sales of its technology partners and subsidiaries.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.